EMVision Medical Devices Ltd

A$1.44As of Sun 8 Nov 2026, 12:00 UTC
ASX:EMVHealthcare
Country Australia
PE (Fwd) •••
TSR 8Y CAGR 19.73%
Div yield —
ROE (66.39%)
Medical Devices
Beta (5Y) 1.11
PE TTM —
TSR TTM (21.95%)
Mkt cap A$133.9M
ROIC (33.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.73
20.19%
(76.33%)
Hold 9|4|8|4|5
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.03
0.03
0.03
0.03
1.98%
(4.10%)
1.93%
(6.55%)
Revenue$M
12.13
12.59
12.67
13.32
5.62%
10.93%
12.09%
15.07%
Peers (US$91.93M)
Cap (US$)
PE
43.77M
—
39.44M
—
90.86M
—
Capital
TTM
5Y
10Y
Leveragex
4.856
(0.924)
(0.636)
EBIT/Intx
7.405
0.091
0.122
Own earn%
(48.48)
(257.89)
(243.02)
Sh yield%
25.78
22.51
21.97
Owners
Insiders/Inst%
12.55
60.90
Short interest%
4.10
SBC / revenue%
4.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
10–19
$1 testx
0.4
Incr. ROIC%
1